DexCom, Inc. , a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Dexcom stock last closed at $81.99, down 1.04% from the previous day, and has decreased 27.96% in one year. It has underperformed other stocks in the Medical Devices industry by 0.11 percentage points. Dexcom stock is currently +42.54% from its 52-week low of $57.52, and -30.46% from its 52-week high of $117.91.
At the moment, there are 392.11M DXCM shares outstanding. The market capitalization of DXCM is $32.15B. In the past 24 hours, 2.9M DXCM shares were traded.
How to Buy Dexcom Stock
Wondering how to invest in Dexcom stock? Here's how.
Choose where to buy Dexcom stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Dexcom stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Put funds into your brokerage account: Choose your payment method and add your info.
Research Dexcom stock: The Dexcom ticker symbol is DXCM. Is Dexcom stock a good investment? Should you buy shares of DXCM? How do DXCM's underlying business fundamentals look? Do top analysts think Dexcom is a good buy? Why has DXCM's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if DXCM is a good stock to buy).
Execute your DXCM purchase: Decide if you will purchase DXCM shares at the current market price or use a limit order to buy DXCM shares at a particular price.
Keep an eye on your DXCM position: Create a watchlist to monitor your investment in Dexcom stock.
Step 1: Choose where to buy Dexcom stock
You will need an online brokerage account to access the NASDAQ market and buy DXCM stock.
A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global markets: From Technology to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal information so you are able to invest in DXCM stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Dexcom stock
Once you have selected the best place to buy Dexcom stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.
Dexcom quick stats
DXCM Price
$81.99
1w %
-5.4%
1y %
-27.96%
5y %
-17.75%
P/E
60.73x
P/B
14.18x
P/S
7.73x
PEG
2.11x
Revenue
$4.15B
Earnings
$535.20M
Fore. Rev. Growth
11.86%
Fore. Earn. Growth
28.8%
Market Cap
$32.15B
Next Earnings
Jul 23, 2025
Next Dividend
N/A
Dexcom Due Diligence Checks
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
DXCM earnings of $749.80M is not enough to cover its interest payments.
There are more short-term assets than short-term liabilities on the DXCM balance sheet.
There are more short-term assets than long-term liabilities on the DXCM balance sheet.
DXCM's operating cash flow of $964.10M allows it to safely service it's debt of $2.53B.
Failed Financial Due Diligence Checks:
Total DXCM debt is higher than 5 years ago, relative to shareholder equity.
DXCM has a relatively high debt to equity ratio of 1.98.
DXCM profit margin has gone down from 16.8% to 12.9% in the past year.
Is DXCM stock a Buy, Hold, or Sell, according to analysts?
Out of 9 Wall Street analysts who give recommendations on DXCM, the consensus analyst rating on Dexcom is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
Latest DXCM Analyst Upgrades/Downgrades
Jeff Johnson, a top 17% analyst from Baird maintains DXCM with a buy rating and lowers their DXCM price target from $115.00 to $105.00, on May 2, 2025.
Anthony Petrone, a top 11% analyst from Mizuho initiates coverage on DXCM with a buy rating and announces their DXCM price target of $85.00, on Apr 10, 2025.
Patrick Wood, a top 16% analyst from Morgan Stanley maintains DXCM with a hold rating and raises their DXCM price target from $75.00 to $82.00, on Feb 14, 2025.
Issie Kirby, a bottom 35% analyst from Redburn Atlantic upgrades DXCM to a strong buy rating and raises their DXCM price target from $85.00 to $115.00, on Feb 3, 2025.
You can dig deeper into what analysts are forecasting on the Dexcom stock forecast page.
DXCM Momentum
SMA10
84.87
SMA20
85.28
SMA50
77.76
SMA100
79.48
SMA200
76.61
MACD
1.01
MACD Signal
1.94
MACD Histogram
-0.93
RSI
45.8
Stochastic %K
8.36
Stochastic %D
16.99
StochRSI %K
0
StochRSI %D
0
How is DXCM performing as a company?
Last year, DXCM earnings were $535.20M. During the past 5 year, DXCM's earnings have increased by 27.23% per year. This was faster than the Medical Devices industry average of 12.15%.
Last year, DXCM revenue was $4.15B. In the past 5 year, DXCM's revenue has grown by 20.98% per year. This was faster than the Medical Devices industry average of 9.62%.
No, Dexcom doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your DXCM purchase
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly the easiest way to buy.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open Trade button and eToro will execute your order.
If you want more info about investing in stocks on eToro, watch the how to video below:
As of Jun 13, 2025, it costs $81.99 to buy one share of Dexcom stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.122 shares of DXCM.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.